Virax Biolabs Group (VRAX) Stock Price & Financial Analysis
Virax Biolabs Group Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Virax Biolabs Group
What is the current stock price for VRAX?
As of the latest trading session, VRAX stock trades at $0.23. The 52-week range is $0.10–$1.20, with a day range of $0.23–$0.53.
What is the P/E ratio for VRAX?
The P/E ratio (Price-to-Earnings) for VRAX is shown in the Key Statistics section. This valuation metric helps compare Virax Biolabs Group Limited to industry peers.
Does VRAX pay dividends?
Virax Biolabs Group does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for VRAX?
Analyst ratings and recommendations for VRAX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of VRAX?
Virax Biolabs Group's market capitalization is $1.1M, classifying it as a micro-cap company. Virax Biolabs Group operates in the Healthcare sector within the Biotechnology industry.